Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction
暂无分享,去创建一个
[1] Y. Aoyama,et al. Systemic capillary leak syndrome triggered by anti‐programmed death 1 checkpoint inhibitor in psoriasis , 2020, The Journal of dermatology.
[2] C. Lescure,et al. Systemic Capillary Leak Syndrome (Clarkson's Disease) as a Complication of Anti-Programmed Death 1 Immunotherapy. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] Stephanie M. Mutchler,et al. New insights regarding epithelial Na+ channel regulation and its role in the kidney, immune system and vasculature , 2019, Current opinion in nephrology and hypertension.
[4] A. Koyanagi,et al. Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis , 2019, Journal of clinical medicine.
[5] P. Lacal,et al. Therapeutic implication of vascular endothelial growth factor receptor‐1 (VEGFR‐1) targeting in cancer cells and tumor microenvironment by competitive and non‐competitive inhibitors , 2018, Pharmacological research.
[6] H. Uchi,et al. Melanoma and Immune Checkpoint Inhibitors , 2018, Current Oncology Reports.
[7] Matthew D. Hellmann,et al. Immune‐Related Adverse Events Associated with Immune Checkpoint Blockade , 2018, The New England journal of medicine.
[8] James R. Anderson,et al. Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Marc Lambert,et al. Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome. , 2017, The American journal of medicine.
[10] B. Souweine,et al. The Clinical Picture of Severe Systemic Capillary-Leak Syndrome Episodes Requiring ICU Admission , 2017, Critical care medicine.
[11] D. Fisher,et al. Immune and molecular correlates in melanoma treated with immune checkpoint blockade , 2017, Cancer.
[12] S. Mandrekar,et al. Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. , 2010, Mayo Clinic proceedings.
[13] S. Kato,et al. Rapid improvement of life-threatening capillary leak syndrome after stem cell transplantation by bevacizumab. , 2010, Blood.
[14] T. Chatila,et al. Idiopathic systemic capillary leak syndrome: novel therapy for acute attacks. , 2009, The Journal of allergy and clinical immunology.
[15] E. Hachulla,et al. High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome , 2008, Critical care medicine.
[16] B. Clarkson,et al. Cyclical edema and shock due to increased capillary permeability. , 1960, Transactions of the Association of American Physicians.